Authors


Lise Van Susteren, MD

Latest:

Psychiatric Abandonment: Pitfalls and Prevention

What is abandonment? Who is responsible? Where is the line drawn between no liability to treat and abandonment? Read how psychiatrists can protect themselves from the legal ramifications of abandonment.


Liza H. Gold, MD

Latest:

Gun Violence and Medical Professional Organizations: Political Business as Usual?

In November 2018, the National Rifle Association (NRA) taunted physicians by tweeting, “Someone should tell self-important anti-gun doctors to stay in their lane.” In response, physicians, including psychiatrists, insisted that firearm death, suicide, injury, and trauma are indeed our lane.


Lloyd Benjamin, MD

Latest:

Tell Me Something

He wasn’t the first person I met days before I was to start my psychiatric residency, but as I walked about in my new city, he caught my attention much more than most. As psychiatrists, we typically assume that we will hear the inside stories, even if in bits and pieces, that will help us better understand and help patients. But perhaps we are too expectant . . .


Lloyd I. Sederer, MD

Latest:

Learning To Do With (Far) Less: What it Takes to Become a Community Psychiatrist

One doctor shares his story of becoming a community psychiatrist.


Lois W. Choi-kain, MD

Latest:

Mini Quiz: Borderline Personality Disorder

Do personality disorders get a bad rap? Take the quiz and learn more.


Lois Wingerson

Latest:

Gender Differences Should Be Considered in Treatment of Addiction

The molecular events that accompany drug abuse and addiction are different for women than for men, according to new studies presented at the annual meeting of the American Psychiatric Association (APA). As yet, little if any of this knowledge has made its way into gender-based differences in pharmacological and behavioral treatments for addiction. But according to some of the speakers, it could and it should.


Lorenzo Rossaro, MD

Latest:

Depression as Co-Pilot: Clinical Implications of Hepatitis C and Interferon/Ribavirin Treatment

Comorbid substance use disorders may complicate treatment for both the hepatologist and psychiatrist. Comprehensive assessment of psychiatric illness and psychopharmacological management may be critical.


Lori L. Altshuler, MD

Latest:

Postpartum Depression: Risk Factors and Treatment Options

The postpartum period represents a time of increased vulnerability for women, though postpartum disorders are often under-recognized and undertreated.


Lorie A. Ritschel, PhD

Latest:

Biological Consequences and Transgenerational Impact of Violence and Abuse

Every year, more than 1 million children are exposed to sexual or physical abuse or neglect in the US. The research summarized here clearly demonstrates that exposure to stress before adulthood can result in persistent effects on both mental and physical health.


Lorna Wing, MD

Latest:

Catatonia in Autism or the Blind Men and the Elephant

Current treatments for autistic spectrum disorders (ASD) are useful in some cases, but have little enduring impact. This had lead to many parents seeking nonconventional treatments that often border on quackery.


Lorraine S. Roth, MD

Latest:

Recognizing and Avoiding Common Pitfalls in Clinical Psychopharmacology

This article examines the risks involved in prescribing psychotropic medication and offers suggestions for managing those risks to ensure the best possibility for a favorable outcome.


Louis A. Trevisan, MD

Latest:

Update on Geriatric Depression and Anxiety

Many older adults experience loneliness, profound psychosocial changes, and loss. Screening, recognition, and treatment of mood disorders in late life significantly decrease morbidity associated with many problems encountered by the elderly.


Louis J. Mini, MD

Latest:

Merging Administrative and Academic Careers in Psychiatry

In the current climate of psychiatric medicine, changes that greatly impact a psychiatrist's time, income potential and career enjoyment are constantly occurring. Is a career in psychiatric administration and academics a rewarding combination?


Louisa Degenhardt, PhD

Latest:

Illicit Drug Dependence Across the Globe: Results From the Global Burden of Disease 2010 Study

How prevalent is dependence on amphetamines, cocaine, opioids, and other illicit drugs across the world? What is the associated disease burden? Insights here.


Louisa Steiger, MD

Latest:

Shadows on a Wall: Phenomenology in an Acute Care Setting

We present the case of a patient for whom different attending providers had markedly different interpretations. As the case unfolds, we invite you to reflect on your diagnostic understanding of each presentation.


Luc Nicole, MD, MSc

Latest:

A New Adaptation of Integrated Psychological Treatment for Patients With Schizophrenia

Integrated psychological treatment (IPT)--which was developed by a research group in Bern, Switzerland, for patients with schizophrenia--is a distinctive and practical approach to rehabilitation.


Lucas A. Salg, MD

Latest:

Why Aren’t We All in Therapy?

The looming specter of emotional and physical exhaustion in residency often takes hold well into a physician's career. So what are we doing about it?


Lucia Zhang, HBSc Candidate

Latest:

Are Psychiatric Disorders Inflammatory-Based Conditions?

A plethora of studies support the hypothesis that inflammation plays a role in the pathophysiology of major psychiatric disorders.


Lucie Nadeau, MD

Latest:

Taking Culture Into Account When Assessing a Young Patient

This list serves as a guide when treating persons of diverse cultures and backgrounds.


Lucius Ripley, MD

Latest:

Algorithm Project Takes Shape in Texas

We believe that TMAP [The Texas Medication Algorithm Project] is the first large-scale use of medication algorithms, Rush said, "certainly in a community mental health setting. A project like this may help to lay the groundwork for improved public mental health treatment here and in other states as well." Medication algorithms, according to the project directors, consist of "a series of treatment steps, each of which is defined in turn by the clinical response of the patient to the preceding step."


Luke Clark, PhD

Latest:

Mini Quiz: Gambling Disorder

If money is not the lure for problem gamblers, what is?


Lynn Yen, MD

Latest:

An Update on Street and Club Drugs: What Clinicians Need to Know

A review of the pharmacological and symptomatic effects of various classes of designer drugs, including stimulants, hallucinogens, and sedatives.


Lynne Gaby, MD

Latest:

6 Psychotherapy Questions for Medically Ill Patients

A brief psychosocial tool that offers compassionate, tailored care using existential neuroscience, a new perspective for conducting bedside psychotherapy.


M. Katherine Shear, MD

Latest:

Treating Prolonged Grief Disorder: Innovations and Future Directions

What is the best treatment course for prolonged grief disorder?


M. Saleem Ismail, MD

Latest:

Benefits of Early Pharmacological Treatment in Alzheimer Disease

Successful intervention for Alzheimer disease requires an early and timely diagnosis. Caregivers of persons with AD often state that an average of 2 years passes from the onset of symptoms to a formal diagnosis.


M. Zachary Rosenthal, PhD

Latest:

Dialectical Behavior Therapy for Patients Dually Diagnosed With Borderline Personality Disorder and Substance Use Disorders

With its focus on both behavior modification and mindfulness training, dialectical behavior therapy has proven quite effective in treating patients with borderline personality disorder. This article provides a primer on a modified version of this outpatient treatment for borderline patients with substance use disorders, a comorbid condition that may affect as many as two-thirds of patients with BPD.


Ma-li Wong, MD

Latest:

Frontiers in Psychiatric Research

These are exciting times for genetics research: Science magazine chose our new appreciation of human genetic diversity as the scientific breakthrough of the year 2007.1 The year brought a new genetic bonanza with the announcement of the 1000 Genome Project, a plan to capture human diversity by obtaining the entire genome sequence information of 1000 individuals.


Madeleine A. Becker MD, FACLP

Latest:

Conventional and Integrative Approaches to Treating Anxiety in Pregnancy

Women should be provided with multiple options for treatment if they decide to engage in mental health care during this critical period.


Madelyn S. Gould, PhD, MPH

Latest:

Bullying and Suicide

Childhood and adolescent bullying-and, recently, cyberbullying-is a major public health problem with potentially devastating consequences. In any prevention effort, students need hope and to learn the skills to end the abuse, as described here.


Madhukar H. Trivedi, MD

Latest:

Rejecting the Accusation of a Violated STAR*D Protocol

The original STAR*D authors refute claims of a violated protocol.

© 2024 MJH Life Sciences

All rights reserved.